Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bluebird Bio, Inc. (BLUE) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bluebird Bio, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1293971.
Total stock buying since 2013: $900,936.
Total stock sales since 2013: $302,744,213.
Total stock option exercises since 2013: $18,164,530.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 2,674 | $13,092 | 0 | $0 |
| 2024 | 0 | $0 | 53,225 | $32,951 | 0 | $0 |
| 2023 | 0 | $0 | 29,657 | $107,873 | 0 | $0 |
| 2022 | 0 | $0 | 60,375 | $389,963 | 0 | $0 |
| 2021 | 0 | $0 | 32,047 | $1,316,414 | 203,355 | $1,118,452 |
| 2020 | 0 | $0 | 29,953 | $2,487,840 | 600 | $30,306 |
| 2019 | 0 | $0 | 113,356 | $14,484,676 | 89,426 | $3,023,134 |
| 2018 | 0 | $0 | 253,653 | $43,940,267 | 217,526 | $4,893,932 |
| 2017 | 0 | $0 | 568,271 | $74,844,245 | 360,998 | $4,314,958 |
| 2016 | 0 | $0 | 16,898 | $789,291 | 30,986 | $183,782 |
| 2015 | 9,682 | $501,062 | 637,702 | $85,151,065 | 707,734 | $3,728,126 |
| 2014 | 6,469 | $399,874 | 2,827,352 | $78,463,786 | 431,284 | $819,211 |
| 2013 | 0 | $0 | 35,000 | $722,750 | 35,000 | $52,629 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-04-01 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 30,000 | 2.09 | 62,579 |
| 2015-03-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 10,500 | 111.00 | 1,165,489 |
| 2015-03-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 10,500 | 2.09 | 21,945 |
| 2015-03-09 | Cole Jason (SVP, Secy. & General Counsel) | Sale | 10,000 | 112.46 | 1,124,600 |
| 2015-03-09 | Cole Jason (SVP, Secy. & General Counsel) | Option Ex | 10,000 | 22.53 | 225,300 |
| 2015-03-02 | Davidson David (Chief Medical Officer) | Sale | 4,000 | 94.96 | 379,844 |
| 2015-03-02 | Davidson David (Chief Medical Officer) | Option Ex | 4,000 | 2.09 | 8,360 |
| 2015-02-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 10,500 | 85.47 | 897,392 |
| 2015-02-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 10,500 | 2.09 | 21,945 |
| 2015-02-02 | Davidson David (Chief Medical Officer) | Sale | 4,000 | 96.41 | 385,652 |
| 2015-02-02 | Davidson David (Chief Medical Officer) | Option Ex | 4,000 | 2.09 | 8,344 |
| 2015-01-12 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 10,500 | 102.32 | 1,074,318 |
| 2015-01-12 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 10,500 | 2.09 | 21,945 |
| 2015-01-02 | Sullivan Eric (Principal Accounting Officer) | Sale | 3,750 | 90.57 | 339,648 |
| 2015-01-02 | Sullivan Eric (Principal Accounting Officer) | Option Ex | 3,750 | 22.59 | 84,693 |
| 2015-01-02 | Davidson David (Chief Medical Officer) | Sale | 4,000 | 90.58 | 362,300 |
| 2015-01-02 | Davidson David (Chief Medical Officer) | Option Ex | 4,000 | 2.09 | 8,344 |
| 2015-01-02 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 30,000 | 90.57 | 2,717,160 |
| 2015-01-02 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 30,000 | 1.52 | 45,540 |
| 2014-12-19 | Schenkein David P (Director) | Buy | 1,176 | 85.00 | 99,960 |
| 2014-12-19 | Maraganore John (Director) | Buy | 2,352 | 85.00 | 199,920 |
| 2014-12-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 10,500 | 82.15 | 862,575 |
| 2014-12-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 10,500 | 2.09 | 21,945 |
| 2014-12-09 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 33,000 | 77.06 | 2,543,145 |
| 2014-12-09 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 33,000 | 2.09 | 68,970 |
| 2014-12-08 | Davidson David (Chief Medical Officer) | Sale | 13,788 | 46.65 | 643,182 |
| 2014-12-08 | Davidson David (Chief Medical Officer) | Option Ex | 13,788 | 2.09 | 28,761 |
| 2014-12-05 | Davidson David (Chief Medical Officer) | Sale | 1,212 | 45.00 | 54,543 |
| 2014-12-05 | Davidson David (Chief Medical Officer) | Option Ex | 1,212 | 2.09 | 2,528 |
| 2014-12-03 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 41.82 | 125,466 |
| 2014-12-03 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,258 |
| 2014-12-01 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 18,000 | 39.85 | 717,390 |
| 2014-12-01 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 18,000 | .95 | 17,100 |
| 2014-12-01 | Leschly Nick (President and CEO) | Sale | 4,834 | 39.85 | 192,648 |
| 2014-11-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 7,500 | 41.50 | 311,272 |
| 2014-11-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 7,500 | 2.09 | 15,674 |
| 2014-11-03 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 41.68 | 125,031 |
| 2014-11-03 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,258 |
| 2014-11-03 | Leschly Nick (President and CEO) | Sale | 25,000 | 41.68 | 1,041,925 |
| 2014-10-24 | Leschly Nick (President and CEO) | Sale | 33,900 | 40.22 | 1,363,458 |
| 2014-10-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 7,500 | 33.16 | 248,699 |
| 2014-10-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 7,500 | 2.09 | 15,674 |
| 2014-10-09 | Gillis Steven (Director) | Sale | 115,000 | 35.25 | 4,053,864 |
| 2014-10-08 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 34,518 | 33.59 | 1,159,459 |
| 2014-10-08 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 34,518 | 2.09 | 72,142 |
| 2014-10-07 | Gillis Steven (Director) | Sale | 6,700 | 35.15 | 235,505 |
| 2014-10-06 | Gillis Steven (Director) | Sale | 24,100 | 35.16 | 847,355 |
| 2014-10-03 | Gillis Steven (Director) | Sale | 26,635 | 35.74 | 951,934 |
| 2014-10-02 | Gillis Steven (Director) | Sale | 47,554 | 34.87 | 1,658,207 |
| 2014-10-01 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 34.55 | 103,649 |
| 2014-10-01 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,270 |
| 2014-10-01 | Leschly Nick (President and CEO) | Sale | 8,000 | 34.55 | 276,400 |
| 2014-10-01 | Gillis Steven (Director) | Sale | 11,516 | 34.75 | 400,181 |
| 2014-09-30 | Gillis Steven (Director) | Sale | 32,095 | 36.08 | 1,157,987 |
| 2014-09-12 | Trv Gp, Llc (10% Owner) | Sale | 38,000 | 36.59 | 1,390,420 |
| 2014-09-12 | Tepper Robert I (Director) | Sale | 38,000 | 36.59 | 1,390,420 |
| 2014-09-11 | Trv Gp, Llc (10% Owner) | Sale | 87,000 | 36.52 | 3,177,240 |
| 2014-09-11 | Tepper Robert I (Director) | Sale | 87,000 | 36.52 | 3,177,240 |
| 2014-09-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 7,500 | 37.02 | 277,650 |
| 2014-09-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 7,500 | 2.09 | 15,674 |
| 2014-09-02 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 38.00 | 114,000 |
| 2014-09-02 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,270 |
| 2014-09-02 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 18,000 | 38.00 | 684,000 |
| 2014-09-02 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 18,000 | .95 | 17,100 |
| 2014-09-02 | Leschly Nick (President and CEO) | Sale | 8,000 | 38.00 | 304,000 |
| 2014-08-29 | Leschly Nick (President and CEO) | Sale | 2,300 | 40.01 | 92,023 |
| 2014-08-11 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 7,500 | 34.26 | 256,949 |
| 2014-08-11 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 7,500 | 2.09 | 15,674 |
| 2014-08-01 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 33.62 | 100,859 |
| 2014-08-01 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,270 |
| 2014-08-01 | Leschly Nick (President and CEO) | Sale | 8,000 | 33.62 | 268,960 |
| 2014-07-14 | Maraganore John (Director) | Buy | 2,941 | 34.00 | 99,994 |
| 2014-07-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 7,500 | 33.20 | 249,000 |
| 2014-07-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 7,500 | 2.09 | 15,674 |
| 2014-07-03 | Leschly Nick (President and CEO) | Sale | 1,300 | 40.00 | 52,000 |
| 2014-07-02 | Leschly Nick (President and CEO) | Sale | 943 | 40.02 | 37,738 |
| 2014-07-01 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 39.55 | 118,649 |
| 2014-07-01 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,270 |
| 2014-07-01 | Leschly Nick (President and CEO) | Sale | 20,040 | 39.84 | 798,393 |
| 2014-06-20 | Leschly Nick (President and CEO) | Sale | 17,075 | 40.06 | 684,024 |
| 2014-06-16 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 10,000 | 39.84 | 398,400 |
| 2014-06-16 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 10,000 | .95 | 9,500 |
| 2014-06-16 | Leschly Nick (President and CEO) | Sale | 42,925 | 39.96 | 1,715,283 |
| 2014-06-16 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 1,500 | 39.86 | 59,790 |
| 2014-06-16 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 1,500 | 2.09 | 3,135 |
| 2014-06-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 6,000 | 24.23 | 145,380 |
| 2014-06-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 6,000 | 2.09 | 12,540 |
| 2014-06-02 | Davidson David (Chief Medical Officer) | Sale | 3,000 | 22.21 | 66,630 |
| 2014-06-02 | Davidson David (Chief Medical Officer) | Option Ex | 3,000 | 2.09 | 6,270 |
| 2014-06-02 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 8,000 | 22.21 | 177,680 |
| 2014-06-02 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 8,000 | .95 | 7,600 |
| 2014-06-02 | Leschly Nick (President and CEO) | Sale | 5,000 | 22.21 | 111,050 |
| 2014-05-14 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 1,500 | 20.03 | 30,045 |
| 2014-05-14 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 1,500 | 2.09 | 3,135 |
| 2014-05-12 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 4,500 | 18.93 | 85,185 |
| 2014-05-12 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 4,500 | 2.09 | 9,405 |
| 2014-05-07 | Leschly Nick (President and CEO) | Option Ex | 116,266 | 2.09 | 242,995 |
| 2014-05-01 | Davidson David (Chief Medical Officer) | Sale | 4,000 | 19.85 | 79,400 |
| 2014-05-01 | Davidson David (Chief Medical Officer) | Option Ex | 4,000 | 2.09 | 8,360 |
| 2014-05-01 | Leschly Nick (President and CEO) | Sale | 5,000 | 20.07 | 100,350 |
| 2014-04-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 6,000 | 21.29 | 127,740 |
| 2014-04-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 6,000 | 2.09 | 12,540 |
| 2014-04-01 | Davidson David (Chief Medical Officer) | Sale | 4,000 | 22.74 | 90,960 |
| 2014-04-01 | Davidson David (Chief Medical Officer) | Option Ex | 4,000 | 2.09 | 8,360 |
| 2014-04-01 | Leschly Nick (President and CEO) | Sale | 5,000 | 22.74 | 113,699 |
| 2014-03-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 6,000 | 25.80 | 154,800 |
| 2014-03-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 6,000 | 2.09 | 12,540 |
| 2014-03-03 | Davidson David (Chief Medical Officer) | Sale | 8,000 | 24.79 | 198,320 |
| 2014-03-03 | Davidson David (Chief Medical Officer) | Option Ex | 8,000 | 2.09 | 16,720 |
| 2014-03-03 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 8,000 | 24.79 | 198,320 |
| 2014-03-03 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 8,000 | .95 | 7,600 |
| 2014-03-03 | Leschly Nick (President and CEO) | Sale | 5,000 | 24.79 | 123,950 |
| 2014-03-03 | Bain Linda (VP, Fin. & Business Operations) | Sale | 2,500 | 24.79 | 61,975 |
| 2014-03-03 | Bain Linda (VP, Fin. & Business Operations) | Option Ex | 2,500 | 2.09 | 5,225 |
| 2014-02-26 | Bain Linda (VP, Fin. & Business Operations) | Sale | 500 | 25.03 | 12,515 |
| 2014-02-26 | Bain Linda (VP, Fin. & Business Operations) | Option Ex | 500 | 2.09 | 1,045 |
| 2014-02-11 | Bain Linda (VP, Fin. & Business Operations) | Sale | 1,000 | 22.50 | 22,500 |
| 2014-02-11 | Bain Linda (VP, Fin. & Business Operations) | Option Ex | 1,000 | 2.09 | 2,090 |
| 2014-02-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 6,000 | 21.08 | 126,479 |
| 2014-02-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 6,000 | 2.09 | 12,540 |
| 2014-02-03 | Davidson David (Chief Medical Officer) | Sale | 8,000 | 21.30 | 170,400 |
| 2014-02-03 | Davidson David (Chief Medical Officer) | Option Ex | 8,000 | 2.09 | 16,720 |
| 2014-02-03 | Leschly Nick (President and CEO) | Sale | 5,000 | 21.30 | 106,500 |
| 2014-02-03 | Bain Linda (VP, Fin. & Business Operations) | Sale | 3,500 | 21.30 | 74,550 |
| 2014-02-03 | Bain Linda (VP, Fin. & Business Operations) | Option Ex | 3,500 | 2.09 | 7,314 |
| 2014-01-22 | Bain Linda (VP, Fin. & Business Operations) | Sale | 2,500 | 25.11 | 62,775 |
| 2014-01-22 | Bain Linda (VP, Fin. & Business Operations) | Option Ex | 2,500 | 2.09 | 5,225 |
| 2014-01-21 | Trv Gp, Llc (10% Owner) | Sale | 250,000 | 23.91 | 5,977,500 |
| 2014-01-21 | Tepper Robert I (Director) | Sale | 250,000 | 23.91 | 5,977,500 |
| 2014-01-17 | Trv Gp, Llc (10% Owner) | Sale | 14,000 | 23.96 | 335,440 |
| 2014-01-17 | Tepper Robert I (Director) | Sale | 14,000 | 23.96 | 335,440 |
| 2014-01-16 | Trv Gp, Llc (10% Owner) | Sale | 33,000 | 24.02 | 792,660 |
| 2014-01-16 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 10,000 | 23.52 | 235,200 |
| 2014-01-16 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 10,000 | .95 | 9,500 |
| 2014-01-16 | Tepper Robert I (Director) | Sale | 33,000 | 24.02 | 792,660 |
| 2014-01-15 | Trv Gp, Llc (10% Owner) | Sale | 260,000 | 22.14 | 5,756,400 |
| 2014-01-15 | Tepper Robert I (Director) | Sale | 260,000 | 22.14 | 5,756,400 |
| 2014-01-14 | Trv Gp, Llc (10% Owner) | Sale | 270,000 | 21.91 | 5,915,700 |
| 2014-01-14 | Tepper Robert I (Director) | Sale | 270,000 | 21.91 | 5,915,700 |
| 2014-01-13 | Trv Gp, Llc (10% Owner) | Sale | 45,000 | 21.80 | 981,000 |
| 2014-01-13 | Tepper Robert I (Director) | Sale | 45,000 | 21.80 | 981,000 |
| 2014-01-10 | Trv Gp, Llc (10% Owner) | Sale | 25,000 | 21.98 | 549,500 |
| 2014-01-10 | Walsh Jeffrey T. (Chief Operating Officer) | Sale | 6,000 | 21.98 | 131,880 |
| 2014-01-10 | Walsh Jeffrey T. (Chief Operating Officer) | Option Ex | 6,000 | 2.09 | 12,540 |
| 2014-01-10 | Tepper Robert I (Director) | Sale | 25,000 | 21.98 | 549,500 |
| 2014-01-03 | Davidson David (Chief Medical Officer) | Sale | 5,000 | 20.99 | 104,949 |
| 2014-01-03 | Davidson David (Chief Medical Officer) | Option Ex | 5,000 | 2.09 | 10,450 |
| 2014-01-03 | Bain Linda (VP, Fin. & Business Operations) | Sale | 2,000 | 20.99 | 41,980 |
| 2014-01-03 | Bain Linda (VP, Fin. & Business Operations) | Option Ex | 2,000 | 2.09 | 4,180 |
| 2014-01-02 | Davidson David (Chief Medical Officer) | Sale | 10,000 | 20.83 | 208,299 |
| 2014-01-02 | Davidson David (Chief Medical Officer) | Option Ex | 10,000 | 2.09 | 20,900 |
| 2014-01-02 | Leschly Nick (President and CEO) | Sale | 5,000 | 20.83 | 104,149 |
| 2014-01-02 | Bain Linda (VP, Fin. & Business Operations) | Sale | 3,000 | 20.83 | 62,489 |
| 2014-01-02 | Bain Linda (VP, Fin. & Business Operations) | Option Ex | 3,000 | 2.09 | 6,270 |
| 2013-12-16 | Davidson David (Chief Medical Officer) | Sale | 15,000 | 20.65 | 309,750 |
| 2013-12-16 | Davidson David (Chief Medical Officer) | Option Ex | 15,000 | 2.09 | 31,349 |
| 2013-12-16 | Finer Mitchell H. (Chief Scientific Officer) | Sale | 18,000 | 20.65 | 371,700 |
| 2013-12-16 | Finer Mitchell H. (Chief Scientific Officer) | Option Ex | 18,000 | .95 | 17,100 |
| 2013-12-16 | Bain Linda (VP, Fin. & Business Operations) | Sale | 2,000 | 20.65 | 41,300 |
| 2013-12-16 | Bain Linda (VP, Fin. & Business Operations) | Option Ex | 2,000 | 2.09 | 4,180 |
Insider trading activities including stock purchases, stock sales, and option exercises of BLUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bluebird Bio, Inc. (symbol BLUE, CIK number 1293971) see the Securities and Exchange Commission (SEC) website.